The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Dealing with biofilms of Pseudomonas aeruginosa and Staphylococcus aureus: In vitro evaluation of a novel aerosol formulation of silver sulfadiazine
Abstract
The risk of infection of skin and soft tissue chronic wounds by gram-negative and gram-positive pathogens growing in biofilms is a major health-care concern. In this study we test a formulation of silver sulfadiazine, vitamin A and lidocaine (AF-SSD) for aerosol administration against biofilms of Pseudomonas aeruginosa and biofilms of methicillin-resistant (MRSA) and methicillin-sensitive (MSSA) strains of Staphylococcus aureus. The aerosol allows the administration of AF-SSD without the direct contact with the wound and avoids contamination of the product after reiterative usage. We evaluated in vitro the anti-biofilm activity of AF-SSD by carrying out different technical approaches such as resazurin assays to measure metabolic activity/viability, crystal violet staining assays to determine biofilm biomass, counting of CFUs and live/dead staining for confocal microscopy analysis. AF-SSD clearly affected biofilm viability, biomass and structure, in the three bacterial strains tested. AF-SSD displayed a strong anti-biofilm effect, showing total bactericidal activity on biofilms of P. aeruginosa at a 400-fold dilution of the product, and after a 100-fold and 10-fold dilution for MRSA and MSSA, respectively. Considering the benefits of aerosol administration, our results support this kind of formulation as a potential improvement over conventional treatments with silver sulfadiazine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The risk of infection represents a general concern in skin and soft tissue open wounds, where each phase of wound healing is challenged by the possibility of microbial infection.34,35”
From Antimicrobial Wound Dressings against Fluorescent and Methicillin-Sensitive Intracellular Pathogenic Bacteria (2020) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mobile Genetic Elements Associated with Antimicrobial Resistance
Partridge, S. R., Kwong, S. M., Firth, N., & Jensen, S. O. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00088-17 · Cited by 2,751
Sarker, S. D., Nahar, L., & Kumarasamy, Y. (2007) · Methods · doi:10.1016/j.ymeth.2007.01.006 · Cited by 1,849
Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S. (2005) · Clinical Infectious Diseases · doi:10.1086/432803 · Cited by 1,404
Research works printed but not linked: 41
- Kennedy, 2010, Burns, biofilm and a new appraisal of burn wound sepsis, Burns, 36, 49, 10.1016/j.burns.2009.02.017 · DOI · Paper page
- Malone, 2017, The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data, J Wound Care, 26, 20, 10.12968/jowc.2017.26.1.20 · DOI · Paper page
- Omar, 2017, Microbial biofilms and chronic wounds, Microorganisms, 5, 9, 10.3390/microorganisms5010009 · DOI · Paper page
- Percival, 2012, A review of the scientific evidence for biofilms in wounds, Wound Repair Regen, 20, 647, 10.1111/j.1524-475X.2012.00836.x · DOI · Paper page
- Hall-Stoodley, 2004, Bacterial biofilms: from the natural environment to infectious diseases, Nat Rev Microbiol, 2, 95, 10.1038/nrmicro821 · DOI · Paper page
- Stoodley, 2002, Biofilms as complex differentiated communities, Annu Rev Microbiol, 56, 187, 10.1146/annurev.micro.56.012302.160705 · DOI · Paper page
- Costerton, 1995, Microbial biofilms, Annu Rev Microbiol, 49, 711, 10.1146/annurev.mi.49.100195.003431 · DOI · Paper page
- Bodey, 1983, Infections caused by Pseudomonas aeruginosa, Rev Infect Dis, 5, 279, 10.1093/clinids/5.2.279 · DOI · Paper page
- Chambers, 2009, Waves of resistance: Staphylococcus aureus in the antibiotic era, Nat Rev Microbiol, 7, 629, 10.1038/nrmicro2200 · DOI · Paper page
- El Zowalaty, 2015, Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies, Future Microbiol, 10, 1683, 10.2217/fmb.15.48 · DOI · Paper page
- Jarvis, 1992, Predominant pathogens in hospital infections, J Antimicrob Chemother, 29, 19, 10.1093/jac/29.suppl_A.19 · DOI · Paper page
- Schaberg, 1991, Major trends in the microbial etiology of nosocomial infection, Am J Med, 91, 10.1016/0002-9343(91)90346-Y · DOI · Paper page
- Moradali, 2017, Pseudomonas aeruginosa lifestyle: a paradigm for adaptation, survival, and persistence, Front Cell Infect Microbiol, 7, 39, 10.3389/fcimb.2017.00039 · DOI · Paper page
- Richardson, 2018, Gene exchange drives the ecological success of a multi-host bacterial pathogen, Nat Ecol Evol, 2, 1468, 10.1038/s41559-018-0617-0 · DOI · Paper page
- Skippington, 2011, Lateral genetic transfer and the construction of genetic exchange communities, FEMS Microbiol Rev, 35, 707, 10.1111/j.1574-6976.2010.00261.x · DOI
- Koo, 1989, Assessment of topical therapy of the burn wound with silver sulphadiazine after its use for 15 years in a burn unit, Burns, 15, 193, 10.1016/0305-4179(89)90182-4 · doi:10.1016/0305-4179(89)90182-4
- Marx, 2014, Silver in medicine: the basic science, Burns, 40, S9, 10.1016/j.burns.2014.09.010 · DOI
- Barillo, 2014, Silver in medicine: a brief history BC 335 to present, Burns, 40, S3, 10.1016/j.burns.2014.09.009 · DOI · Paper page
- Sibbald, 2017, Update: topical antimicrobial agents for chronic wounds, Adv Skin Wound Care, 30, 438, 10.1097/01.ASW.0000524471.28441.b9 · doi:10.1097/01.asw.0000524471.28441.b9
- Martínez, 2016, Linezolid as an eradication agent against assembled methicillin-resistant Staphylococcus aureus biofilms, RSC Adv, 6, 101023, 10.1039/C6RA19670E · doi:10.1039/c6ra19670e
- O’Toole, 1998, Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis, Mol Microbiol, 28, 449, 10.1046/j.1365-2958.1998.00797.x · DOI · Paper page
- Hudman, 2013, Resazurin-based assay for screening bacteria for radiation sensitivity, Springerplus, 2, 55, 10.1186/2193-1801-2-55 · DOI
- Sandberg, 2009, Pros and cons of using resazurin staining for quantification of viable Staphylococcus aureus biofilms in a screening assay, J Microbiol Methods, 78, 104, 10.1016/j.mimet.2009.04.014 · DOI
- Beaudoin, 2018, Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms, Sci Rep, 8, 14728, 10.1038/s41598-018-33016-7 · doi:10.1038/s41598-018-33016-7
- Toledo-Arana, 2005, Staphylococcus aureus develops an alternative, ica-independent biofilm in the absence of the arlRS two-component system, J Bacteriol, 187, 5318, 10.1128/JB.187.15.5318-5329.2005 · DOI · Paper page
- Kalan, 2017, Targeting biofilms of multidrug-resistant bacteria with silver oxynitrate, Int J Antimicrob Agents, 49, 719, 10.1016/j.ijantimicag.2017.01.019 · DOI
- Denny, 1978, A preliminary report on the spray application of topical silver sulfadiazine to burn wounds, J Trauma, 18, 730, 10.1097/00005373-197810000-00010 · doi:10.1097/00005373-197810000-00010
- Bjarnsholt, 2007, Silver against Pseudomonas aeruginosa biofilms, APMIS, 115, 921, 10.1111/j.1600-0463.2007.apm_646.x · DOI · Paper page
- Akiyama, 1998, Effects of sucrose and silver on Staphylococcus aureus biofilms, J Antimicrob Chemother, 42, 629, 10.1093/jac/42.5.629 · doi:10.1093/jac/42.5.629
- Schuenck, 2004, Oxacillin- and mupirocin-resistant Staphylococcus aureus: in vitro activity of silver sulphadiazine and cerium nitrate in hospital strains, J Chemother, 16, 453, 10.1179/joc.2004.16.5.453 · doi:10.1179/joc.2004.16.5.453
- Percival, 2019, Silver, biofilms and wounds: resistance revisited, Crit Rev Microbiol, 1
- Ranieri, 2018, Mechanisms of biofilm stimulation by subinhibitory concentrations of antimicrobials, Curr Opin Microbiol, 45, 164, 10.1016/j.mib.2018.07.006 · DOI
- Elliott, 2010, Exploratory study of the prevalence and clinical significance of tobramycin-mediated biofilm induction in Pseudomonas aeruginosa isolates from cystic fibrosis patients, Antimicrob Agents Chemother, 54, 3024, 10.1128/AAC.00102-10 · doi:10.1128/aac.00102-10
- Hoffman, 2005, Aminoglycoside antibiotics induce bacterial biofilm formation, Nature, 436, 1171, 10.1038/nature03912 · DOI · Paper page
- Linares, 2006, Antibiotics as intermicrobial signaling agents instead of weapons, Proc Natl Acad Sci U S A, 103, 19484, 10.1073/pnas.0608949103 · DOI · Paper page
- Kaplan, 2012, Low levels of beta-lactam antibiotics induce extracellular DNA release and biofilm formation in Staphylococcus aureus, MBio, 3, 10.1128/mBio.00198-12 · DOI · Paper page
- Fu, 2007, Physiological role of retinyl palmitate in the skin, Vitam Horm, 75, 223, 10.1016/S0083-6729(06)75009-9 · DOI
- Hunt, 1986, Vitamin A and wound healing, J Am Acad Dermatol, 15, 817, 10.1016/S0190-9622(86)70238-7 · DOI · Paper page
- MacKay, 2003, Nutritional support for wound healing, Altern Med Rev, 8, 359
- Ong, 2018, Current anti-biofilm strategies and potential of antioxidants in biofilm control, Expert Rev Anti Infect Ther, 16, 855, 10.1080/14787210.2018.1535898 · DOI
- Boles, 2008, Endogenous oxidative stress produces diversity and adaptability in biofilm communities, Proc Natl Acad Sci U S A, 105, 12503, 10.1073/pnas.0801499105 · DOI · Paper page
Cited by
Garcia-Salinas, S., Gámez, E., Landa, G., Arruebo, M., Irusta, S., & Mendoza, G. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c17043 · Cited by 19
Metadata
- Authors
- Moyano, A. J., Mas, C. R., Colque, C. A., & Smania, A. M.
- Venue
- Burns
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 46
- Issue
- 1
- Pages
- 128-135
- ISSN
- 0305-4179
- Cited by
- 23
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.